Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000057EBVENSG00000156689.7protein_codingGLYATL2NoNo219970Q8WU03
TVIS30077117HIVENSG00000156689.7protein_codingGLYATL2NoNo219970Q8WU03
TVIS20010630HPVENSG00000156689.7protein_codingGLYATL2NoNo219970Q8WU03
TVIS20049508HPVENSG00000156689.7protein_codingGLYATL2NoNo219970Q8WU03
TVIS44046675HTLV-1ENSG00000156689.7protein_codingGLYATL2NoNo219970Q8WU03
TCGA Plot Options
Drug Information
GeneGLYATL2
DrugBank IDDB00145
Drug NameGlycine
Target IDBE0002306
UniProt IDQ8WU03
Regulation Typesubstrate
PubMed IDs20305126
CitationsWaluk DP, Schultz N, Hunt MC: Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J. 2010 Aug;24(8):2795-803. doi: 10.1096/fj.09-148551. Epub 2010 Mar 19.
GroupsApproved; Nutraceutical; Vet_approved
Direct ClassificationAlpha amino acids
SMILESNCC(O)=O
Pathwaysgamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling
PharmGKBPA449789
ChEMBLCHEMBL773